| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell Biology Section, Laboratory of Viral Carcinogenesis, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland 21702
To better understand the molecular mechanism of multistage carcinogenesis, we have attempted to identify putative oncogenes and/or tumor suppressor genes involved in preneoplastic-to-neoplastic progression of mouse epidermal JB6 variants. The JB6 variants consist of P- (promotion resistant), P+ (promotion sensitive), and Tx [transformed; both apoptosissensitive (As) and apoptosis-resistant (Ar)] cells, representing progression from early to late stages of carcinogenesis. By using the newly developed differential mRNA display technique, we have isolated five clones from these JB6 variants. The isolated clones were uniquely expressed either in P-/P+ cells or in Tx (As/Ar) cells or showed highly differential expression among the variants. The expression pattern shown by differential mRNA display was confirmed by Northern blot analysis. DNA sequencing followed by computer search against Genbank and EMBL DNA databases indicates that three clones are novel and two have high homology with recorded genes. One of the clones (Cl.14), which detects expression in preneoplastic not neoplastic JB6 cells, was used as a probe for complementary DNA library screening. The corresponding gene, named sun for specifically unexpressed in neoplastic JB6 cells, was isolated and sequenced. The longest open reading frame of the sun clone predicts a peptide showing 96% amino acid sequence identity to the recorded sequence of human tissue inhibitor of metalloproteinases-3, one of a family of genes implicated in tumorigenesis and tumor invasion. This is the first report, to our knowledge, of the simultaneous display of mRNAs of four phenotypically distinct cell variants and of the isolation of five clones which may be associated with specific stages of tumor promotion and/or progression and apoptosis.
1 To whom requests for reprints should be addressed.
Received 10/ 4/93. Accepted 1/20/94.
This article has been cited by other articles:
![]() |
Q. Gu, M. Tan, and Y. Sun SAG/ROC2/Rbx2 Is a Novel Activator Protein-1 Target that Promotes c-Jun Degradation and Inhibits 12-O-Tetradecanoylphorbol-13-Acetate-Induced Neoplastic Transformation Cancer Res., April 15, 2007; 67(8): 3616 - 3625. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-F. Thai, J. W. Allen, A. B. DeAngelo, M. H. George, and J. C. Fuscoe Detection of early gene expression changes by differential display in the livers of mice exposed to dichloroacetic acid Carcinogenesis, August 1, 2001; 22(8): 1317 - 1322. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Murakami, K. Kawabata, T. Koshiba, G. Gao, Y. Nakamura, K. Koshimizu, and H. Ohigashi Nitric Oxide Synthase Is Induced in Tumor Promoter-sensitive, but not Tumor Promoter-resistant, JB6 Mouse Epidermal Cells Cocultured with Interferon- {{gamma}}-stimulated RAW 264.7 Cells: The Role of Tumor Necrosis Factor-{{alpha}} Cancer Res., November 1, 2000; 60(22): 6326 - 6331. [Abstract] [Full Text] |
||||
![]() |
S. M. Wang, S. C. Fears, L. Zhang, J.-J. Chen, and J. D. Rowley From the Cover: Screening poly(dA/dT)- cDNAs for gene identification PNAS, April 11, 2000; 97(8): 4162 - 4167. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-L. Li, J. A. Blackford, C. S. Judge, M. Liu, W. Xiao, D. V. Kalvakolanu, and B. A. Hassel RNase-L-dependent Destabilization of Interferon-induced mRNAs. A ROLE FOR THE 2-5A SYSTEM IN ATTENUATION OF THE INTERFERON RESPONSE J. Biol. Chem., March 17, 2000; 275(12): 8880 - 8888. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Cmarik, H. Min, G. Hegamyer, S. Zhan, M. Kulesz-Martin, H. Yoshinaga, S. Matsuhashi, and N. H. Colburn Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation PNAS, November 23, 1999; 96(24): 14037 - 14042. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tan, S. Li, M. Swaroop, K. Guan, L. W. Oberley, and Y. Sun Transcriptional Activation of the Human Glutathione Peroxidase Promoter by p53 J. Biol. Chem., April 23, 1999; 274(17): 12061 - 12066. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Duan, Y. Wang, M. Aviram, M. Swaroop, J. A. Loo, J. Bian, Y. Tian, T. Mueller, C. L. Bisgaier, and Y. Sun SAG, a Novel Zinc RING Finger Protein That Protects Cells from Apoptosis Induced by Redox Agents Mol. Cell. Biol., April 1, 1999; 19(4): 3145 - 3155. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. D. Pennie, G. A. Hegamyer, M. R. Young, and N. H. Colburn Specific Methylation Events Contribute to the Transcriptional Repression of the Mouse Tissue Inhibitor of Metalloproteinases-3 Gene in Neoplastic Cells Cell Growth Differ., April 1, 1999; 10(4): 279 - 286. [Abstract] [Full Text] |
||||
![]() |
J. T. Fleming, W.-H. Yao, and G. S. Sayler Optimization of Differential Display of Prokaryotic mRNA: Application to Pure Culture and Soil Microcosms Appl. Envir. Microbiol., October 1, 1998; 64(10): 3698 - 3706. [Abstract] [Full Text] |
||||
![]() |
T. Andreu, T. Beckers, E. Thoenes, P. Hilgard, and H. von Melchner Gene Trapping Identifies Inhibitors of Oncogenic Transformation. THE TISSUE INHIBITOR OF METALLOPROTEINASES-3 (TIMP3) AND COLLAGEN TYPE I alpha 2 (COL1A2) ARE EPIDERMAL GROWTH FACTOR-REGULATED GROWTH REPRESSORS J. Biol. Chem., May 29, 1998; 273(22): 13848 - 13854. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bian and Y. Sun p53CP, a putative p53 competing protein that specifically binds to the consensus p53 DNA binding sites: A third member of the p53 family? PNAS, December 23, 1997; 94(26): 14753 - 14758. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kasukabe, J. Okabe-Kado, and Y. Honma TRA1, a Novel mRNA Highly Expressed in Leukemogenic Mouse Monocytic Sublines But Not in Nonleukemogenic Sublines Blood, April 15, 1997; 89(8): 2975 - 2985. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sun, G. Hegamyer, H. Kim, K. Sithanandam, H. Li, R. Watts, and N. H. Colburn Molecular Cloning of Mouse Tissue Inhibitor of Metalloproteinases-3 and Its Promoter J. Biol. Chem., August 18, 1995; 270(33): 19312 - 19319. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |